AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Healthcare Strategy Consulting Expert Sheldon Ng Joins Navigant to Bolster Life Sciences and Provider Collaboration

May 22, 2019

CHICAGO--(BUSINESS WIRE)--May 22, 2019--

Navigant (NYSE: NCI) today announced that Sheldon Ng has joined the firm as a managing director in its life sciences practice. In this role, Ng will lead Navigant’s San Francisco-based life sciences strategy consulting team and spearhead the firm’s center of excellence focused on supporting biopharmaceutical and medical technology strategic partnerships with health systems.

“Today’s highly specialized and complex healthcare ecosystem requires pharmaceutical and medical device companies to seek new insights and methodologies to help answer critical business questions,” said Eduardo Schur, managing director and leader of Navigant’s global life sciences practice. “Sheldon’s depth of expertise will further our commitment to advancing multi-stakeholder partnerships among our provider, payer, and life sciences clients to the benefit of patients worldwide.”

Ng brings nearly two decades of experience partnering with emerging and established biopharmaceutical and medical technology companies in areas such as intelligent personalized healthcare, value-based solutions, and strategic account management. He previously served as the vice president of strategy and analytics at Locust Walk, where he launched a practice to accelerate partnering and financing life sciences transactions. Previously, Ng led the commercial strategy practice for Health Advances and was head of Promidian’s San Francisco office, where he was responsible for establishing its West Coast business. Ng also held commercial and scientific leadership positions at IQVIA (formerly IMS Consulting Group), Hana Biosciences, Guava Technologies, Exelixis, and Chiron.

Navigant’s life sciences practice is comprised of specialized consultants, former pharmaceutical and medical technology executives, clinicians, researchers, and other experts with decades of strategy, operational consulting, compliance, regulatory, and reimbursement services experience. Professionals collaborate with life sciences clients, as well as hospitals and health systems, physician enterprises, payers, and government, to provide strategic management solutions. Navigant’s life sciences practice is a part of the firm’s Healthcare segment.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant’s professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage, and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the firm primarily serves clients in the healthcare, energy, and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, our practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at navigant.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190522005065/en/

CONTACT: Kyle Bland

Navigant Investor Relations

312.573.5624

kyle.bland@navigant.com

Alven Weil

Navigant

704.995.5607

alven.weil@navigant.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA ILLINOIS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PROFESSIONAL SERVICES CONSULTING OTHER PROFESSIONAL SERVICES OTHER SCIENCE SCIENCE GENERAL HEALTH

SOURCE: Navigant

Copyright Business Wire 2019.

PUB: 05/22/2019 07:00 AM/DISC: 05/22/2019 07:41 AM

http://www.businesswire.com/news/home/20190522005065/en

All contents © copyright 2019 The Associated Press.All rights reserved.